Your browser doesn't support javascript.
loading
Favipiravir for symptomatic COVID-19: A nationwide observational cohort study.
Doi, Yohei; Ishihara, Takuma; Banno, Sumi; Ando, Masahiko; Kondo, Masashi.
Affiliation
  • Doi Y; Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: yoheidoi@fujita-hu.ac.jp.
  • Ishihara T; Innovative and Clinical Research Promotion Center, Gifu University Hospital, Yanagido, Gifu, Japan.
  • Banno S; Center for Clinical Trial and Research Support, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Ando M; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Aichi, Japan.
  • Kondo M; Center for Clinical Trial and Research Support, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
J Infect Chemother ; 29(2): 150-156, 2023 Feb.
Article in En | MEDLINE | ID: mdl-36307058

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic_studies / Etiology_studies / Observational_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic_studies / Etiology_studies / Observational_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Country of publication: Netherlands